Walgreens Informs Theranos to Cease Use of its Newark, Calif. Lab for Blood Test Analysis

Theranos testing services at Palo Alto, Calif., store are immediately
suspended

DEERFIELD, Ill.–(BUSINESS WIRE)–In light of the letter dated Jan. 25 from the Centers for Medicare and
Medicaid Services (CMS) to Theranos, Inc., Walgreens said today that it
has informed Theranos that it must immediately cease sending any
clinical laboratory tests provided through Theranos Wellness Centers at
Walgreens to the Theranos lab in Newark, Calif., for analysis. In
addition, Walgreens is suspending Theranos laboratory services at its
Palo Alto, Calif., store, effective immediately.

Walgreens informed Theranos that tests collected at 40 Theranos Wellness
Centers located at stores in Arizona must be sent only to Theranos’
certified lab in the Phoenix area or to an accredited third-party lab
for analysis. No patient samples will be sent to the Newark lab until
all issues raised by CMS have been fully resolved.

Contacts

Walgreens
Michael Polzin, 847-315-2920
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens